Novo Nordisk announced that it is lowering prices for its blockbuster obesity and diabetes drugs for cash-paying patients.

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without ...

Novo NordiskNVO undercut Eli LillyLLY and the Trump administration on Monday, slashing the cash price of its drugs Wegovy and ...

For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...

Novo Nordisk A/S faces intensifying GLP-1 competition, notably from Eli Lilly, prompting price cuts for Wegovy. Learn more ...

Novo Nordisk plans “all in” launch of Wegovy pill in the US market and will cut price of the drug's injectable option in the ...

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

Dow Jones Top Company Headlines at 3 PM ET: Novo Nordisk Cuts Prices for Obesity Drugs | What ... The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for ...

Novo Nordisk offers Ozempic Wegovy sold 199 per month for new self-paying patients from Nov. 17 to March 31 with discounted initial doses.

Novo Nordisk has more than enough of its Wegovy weight-loss pills to support an aggressive product launch, CEO Mike Doustdar ...